The 18th CXL Experts’ Meeting, led by ELZA’s CMO, Prof. Farhad Hafezi, was held last weekend in Zurich, Switzerland.
The ELZA team of surgeons and researchers were all in attendance, and today saw Prof. Hafezi give the attending delegates a lecture on “How to treat thin corneas”, where he examined the history of performing corneal cross-linking (CXL) for the treatment of corneal ectasias like keratoconus. He then brought delegates up-to-date on the research that has been performed over the years to improve how thin corneas are cross-linked. Finally, Prof. Hafezi demonstrated the results of the latest thin cornea cross-linking protocol, sub400, developed by ELAZA, which simplifies the process, and can let surgeons, for the first time, cross-link corneas that are as thin as 200 µm.
The Brazilian Association of Cataract and Refractive Surgery (BRASCRS) awarded the ELZA Institute’s Dr. Emilio Torres-Netto the José Ignacio Barraquer Medal, in recognition of his
Dr. Emilio Torres-Netto, MD, PhD, is a cornea and cataract surgeon at the ELZA Institute in Zurich. Emilio was featured in this month’s issue of
The ELZA Institute had a strong presence at the 82nd SBAO annual congress in Bern. Prof. Kaweh Mansouri, Dr. Emilio Torres-Netto and Ms. Julia Schinzel all
Today, a landmark PACK-CXL trial was published that shows that PACK-CXL is an effective corneal infection therapy.
Researchers from ELZA, the ETH Zurich, the University of Zurich and the University of South Florida investigate corneal biomechanics in a mouse model for Ehlers-Danlos
Is it useful to cool the cornea during cross-linking? The researchers at ELZA are constantly trying to improve corneal cross-linking. Back in 2013, we identified
